Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria

NCT05780840 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT05780840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05780840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria
Lead sponsor
Bispebjerg Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
February 23, 2023
Completion date
September 30, 2024
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythropoietic protoporphyria